DOI
https://doi.org/10.18849/ve.v1i1.17Abstract
Clinical bottom line
At normal clinical doses, there is no evidence that robenacoxib would provide superior patient comfort compared to meloxicam.
References
Schmid, V.B. et al. (2009) Analgesic and anti-inflammatory actions of robenacoxib in acute joint inflammation in dog. Journal of Veterinary Pharmacology and Therapeutics, 33 (2), pp. 118-131. http://dx.doi.org/10.1111/j.1365-2885.2009.01117.x
License
Copyright (c) 2016 Adam Swallow
This work is licensed under a Creative Commons Attribution 4.0 International License.
Veterinary Evidence uses the Creative Commons copyright Creative Commons Attribution 4.0 International License. That means users are free to copy and redistribute the material in any medium or format. Remix, transform, and build upon the material for any purpose, even commercially - with the appropriate citation.
